Urocortin, a new member of the CRF peptide family which also includes urotensin I and sauvagine, was recently cloned from the rat midbrain. The synthetic replicate of urocortin was found to bind with high affinity to type 1 and type 2 CRF receptors and, based upon its anatomic localization within the brain, was proposed to be a natural ligand for the type 2 CRF receptors. Using a genomic library, we have cloned the human counterpart of rat urocortin and localized it to human chromosome 2. Human and rat urocortin share 95% identity within the mature peptide region. Synthetic human urocortin binds with high affinity to CRF receptor types 1, 2~r, and 2p, stimulates CAMP accumulation from cells stably transfected with these receptors, and acts in vitro to release ACTH from dispersed rat anterior pituitary cells. In addition, the CRF-binding protein binds human urocortin with high affinity and can prevent urocortin-stimulated ACTH secretion in vitro. The inhibitory effect of the CRF-binding protein on human urocortin can be blocked by biologically inactive CRF fragments, such as CRF 
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12126195 adenylate cyclase activity of the CRF receptor subtvnes to different degrees (9.14-17): the tvne 2 CR*;eceptors are selecgve fo; Ucn, cro, ani.Svg relative to CRF. These peptides also bind with varying affinities to the binding protein for CRF (CRF-BP) (18, 19) , which has been shown to inactivate CRF (18).
A cDNA probe encoding the peptide region of rat Ucn was used to screen a human genomic library by hybridization. We report the nucleotide and amino a&d sequence of hum& Ucn. We also evaluate the binding and some biolonical activities of this svnthetic peptidi on cells expresling CRF receptors 1, ia, and 2p, as well as on the CRF-BP.
Materials and Methods
Library Screening: Approximately 0.6 x lo6 phage plaques of a human placental genomic library in the EMBL3 SP6/T7 vector (Clontech, Palo Alto, CA) were screened by hybridization using a probe encoding the peptide region of rat Ucn. The 160 bp probe was synthesized by PCR using the oligonucleotides (sense:
5'-TGCAGGCGAG-CGGCAACGACGAGACGA-3' and antisense: 5'-ATACGGGGCCGATCACTTGCCCACCGAG-3'), [a3*P-dCTP], and rat Ucn cDNA (9) as template. Hybridization was carried out at 42'C in standard buffers with 20% formamide. Final washes were at 42°C in 2XSSC/O.l% SDS. The phage DNA from an individual positive plaque was purified and subcloned into pBluescript (Stratagene, La Jolla, CA). Dideoxy sequencing was done using the Sequenase kit (US Biochemical, Cleveland, OH).
Chromosomal Localization:
The human chromosomal localization of Ucn was obtained by probing a Southern blot containing 24 isolated human/rodent somatic cell hybrids (Coriell Cell Repositories, Camden, NJ). The blot was hybridized with the rat Ucn probe described in the library screening above. The final washes for the blots were at 60°C in 0.2XSSC/O. 1 %SDS.
Binding Assays: CHO cell lines were transfected by electroporation with the pRc/RSV or pRc/CMV expression vector (Invitrogen, San Diego, CA) containing the cDNA of either human CRF-RI (lo), rat CRF-R2a (courtesy of Tim Lovenberg, In vitro bidassays: Stably transfected CHO cells expressing human CRF-Rl, rat CRF-R2cr , or mouse CRF-R2P were treated with test peptides as described (9.10). Cells were lysed and the intracellular CAMP levels were measured with an RIA kit (Biomedical Technologies, Stoughton, MA).
Potencies were determined by the Allfit program (21) wtth results expressed as the average &em for .three or more independent assays. Rat anterior pitmtary cells were established in culture (22) and treated in triplicate with test peptides with or without recombinant CRF-BP for three hours as described (19). The media were collected and secreted ACTH was measured with an RIA kit (Diagnostic Products Corp., Los Angeles, CA).
Results and Discussion
A positive clone determined to encode Ucn was obtained from a low stringency hybridization screen of a human genomic library with a probe that encoded the mature peptide region of rat Ucn. The clone had an insert size of approximately 15Kb which was subcloned into pBluescript. Using primers specific to rat Ucn, internal sequence that corresponded to human Ucn was obtained and the complete coding region was sequenced. Similar to the organization of other genes for rat and xenopus CRFs (8,23), the coding region for human Ucn is found on one exon. The nucleotide sequence for human Ucn encodes a 123 amino acid protein comprised of a 79 amino acid precursor and a putative 40 amino acid mature peptide. The mature peptide is preceded by the proteolytic processing site Arg-Arg and followed by amino acids Gly-Lys, presumed to be involved in C-terminal amidation and cleavage of peptides from a precursor. The precise processing of this precursor will not be formally established until the native peptide itself is characterized in human tissues.
The putative mature 40 amino acid human Ucn peptide has 88% identity to rat Ucn at the nucleotide level and 95% identity at the amino acid level. For the full-length protein, human and rat Ucn show 75% identity at the nucleotide level and 73% identity at the amino acid level. Human Ucn is one amino acid longer than rat Ucn in the precursor region. The human Ucn gene is localized to human chromosome 2.
There are two amino acid differences between the human and rat Ucn peptides: at position 2 (Asn for Asp) and at position 4 (Ser for Pro) (Fig. 1) . The change at position 4 is interesting because the Pro-Pro motif is highly conserved in the CRF peptide family, seen in all CRFs, Uros, and Svg. This change is further intriguing because a Pro-Ser, rather than the Pro-Pro consensus, occurs in some of the insect diuretic hormones (24,25), which have also been considered to be part of the CRF superfamily. Among the diuretic hormones, Manduca sexta has the highest homology to human Ucn with 30% identity at the amino acid level.
118 F'-timG k, 117 P " s'v.,q,,,K I :uuccn" Fig. 1 . Amino acid comparison of human and rat urocortin. The alignment was done by the Lasergene alignment system and the Clustal method with an identitv residue weight table. Identical residues are shaded; the square indicates aputative amidation site; and the arrows indicate the putative mature peptide. The nucleotide sequence for human Ucn has been deposited into Genbank under accession number U43177.
Human Ucn is a potent ligand for all three functional CRF receptors identified to date (CRP-Rl, CRF-R2a, and CRF-R2@). The affinity of human Ucn for CRF-Rl is comparable to that of rat Ucn (Table  1) . While CRF-Rl does not appear to markedly discriminate among CRF-related peptides, CRF-R2a and CRF-R2P show definite selectivities. Human and rat (9) Ucn exhibit much greater affinity than rat/human (r/h) CRF for CRF-R2P. Similarly, both human and rat Ucn have approximately lo-fold higher affinity than r/hCRF for CRF-R~CX (Table 1) .
Rat Ucn has a slightly higher affinity than Uro and Svg for CRF-R2P (9) and CRF-R2a (Table 1) ; the affinity of human Ucn is in the same range as the two non-mammalian peptides. The type 2 CRF receptors thus favor Ucn, Uro, and Svg over r/hCRF.
Human Ucn is similarly potent in inducing intracellular CAMP accumulation in CHO cells stably transfected with CRF-Rl, CRF-R2a, or CRF-R2P (Table 2) . Human Ucn acts in the same range as rat Ucn and r/hCRF to induce CAMP levels in cells transfected with CRF-Rl. By contrast, cells expressing CRF-R2P accumulate CAMP in response to human Ucn with approximately 20-fold greater sensitivity than in response to r/hCRF. This effect has also been reported for rat Ucn (9). Human and rat Ucn are at least lofold more potent than r/hCRF in stimulating CAMP accumulation in CRF-R2a transfected cells (Table 2) .
Rat Ucn was found to be a highly potent secretagog for ACTH in vitro, and induced a prolonged elevation of plasma ACTH in the rat in vivo (9). Human Ucn is equipotent to rat Ucn and more potent than r/hCRF, Uro, or Svg in its ability to stimulate ACTH secretion from rat anterior pituitary cells in vitro [ Fig. 2 and (9) ]. Binding properties of human urocortin compared to rat urocortin, rat/human CRF, suckerfish urotensin I, and frog sauvagine on the three known CRF receptor types: 1, 2a, and 2p; and on the CRF-BP. Dissociation constants (Ki) were calculated from three or more experiments for each test peptide. The values are shown with 95% confidence limits. CRF-BP (18), a 37K circulating protein in human plasma, is also distributed throughout the central nervous system (26) of all vertebrates studied thus far, including human beings (27). CRF-BP binds human Ucn with high affinity and in the same range as that seen for rat Ucn and r/hCRF (Table 1) . As has been noted for CRF (19), coincubation with CRP-BP prevents the release of ACTH by human Ucn (Fig. 3) . The actions and distribution of CRF-BP have led us to suggest that CRF-BP may serve lo temporally and anatomically limit the action of Ucn. Furthermore, biologically inactive CRF fragments such as CRF(9-33), which we reported earlier to interfere with the ability of CRF-BP to bind to CRF (19), can also block the inactivation of Ucn by CRF-BP and restore the ability of Ucn to release ACTH (Fig. 3) . Recently, it was reported that CRF-BP-blockers can arouse rats and improve their performance on cognitive tests, by elevating levels of free CRF (27). Appropriate blockers of the CRF-BP might be used therapeutically to elevate levels of free Ucn, as was proposed for CRF (19, 27) . Clearly, more physiological, biochemical and anatomical studies are needed before the funclions and pharmacologic potential of this new mammalian peptide can bc defined. The high affinity of Ucn for all known CRF receptors and its likely role as the native ligand for the brain type 2 CRF receptors in the rat compel further exploration of this ligandlrcccptor signaling system. Endo. 1996 Vol 137. No 5 
